MS Drug Market Expected To reach $9B By 2024
Submitted by art on Thu, 2009-06-11 07:56.
These market analysts are reporting that: The Multiple Sclerosis (MS) Market Has Total Global Revenues of Over $6bn in 2008. It Will Exceed $9bn During the Second Half of Next Decade.
I report this because the "good" side of this is that it means MS drugs can be very lucrative. Which means that pharma and biotech companies will consider MS as a target disease for their products. For the most part, more attention is better.
Good thing I won't be around
Good thing I won't be around to spend the $9b. Not to worry, though, there'll be more of us 'til they tell people how to avoid getting it in the first place.
Fixing us damaged ones is not so lucrative.
...hmmm
except...
If they can find a way to fix everything except the cognitive part. Then we'll be easier marks, but otherwise indistinguishable from ordinary old people.
:^)
Patricia Cooke Smith Hate to
Patricia Cooke Smith
Hate to be so negitive but why would the pharmas come to the forefront and find a cure if they can make so much money with the bandaids that they sell now for an arm and a leg. Lost in the June glooms in Oceanside, Pat